Logo image of CJMB

CALLAN JMB INC (CJMB) Stock Fundamental Analysis

NASDAQ:CJMB - Nasdaq - US1311001093 - Common Stock - Currency: USD

5.1  -0.3 (-5.56%)

After market: 5.1 0 (0%)

Fundamental Rating

3

Taking everything into account, CJMB scores 3 out of 10 in our fundamental rating. CJMB was compared to 22 industry peers in the Air Freight & Logistics industry. CJMB has a great financial health rating, but its profitability evaluates not so good. CJMB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CJMB has reported negative net income.
In the past year CJMB had a positive cash flow from operations.
CJMB Yearly Net Income VS EBIT VS OCF VS FCFCJMB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

The Return On Assets of CJMB (-45.13%) is worse than 72.73% of its industry peers.
CJMB's Return On Equity of -72.28% is on the low side compared to the rest of the industry. CJMB is outperformed by 68.18% of its industry peers.
Industry RankSector Rank
ROA -45.13%
ROE -72.28%
ROIC N/A
ROA(3y)6.05%
ROA(5y)N/A
ROE(3y)-1.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CJMB Yearly ROA, ROE, ROICCJMB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

The Gross Margin of CJMB (39.05%) is better than 81.82% of its industry peers.
The Profit Margin and Operating Margin are not available for CJMB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CJMB Yearly Profit, Operating, Gross MarginsCJMB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40

More info and screens

9

2. Health

2.1 Basic Checks

CJMB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CJMB remains at a similar level compared to 1 year ago.
There is no outstanding debt for CJMB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CJMB Yearly Shares OutstandingCJMB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CJMB Yearly Total Debt VS Total AssetsCJMB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 7.20 indicates that CJMB is not in any danger for bankruptcy at the moment.
CJMB has a better Altman-Z score (7.20) than 86.36% of its industry peers.
There is no outstanding debt for CJMB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.2
ROIC/WACCN/A
WACC9.05%
CJMB Yearly LT Debt VS Equity VS FCFCJMB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5M 10M

2.3 Liquidity

CJMB has a Current Ratio of 2.59. This indicates that CJMB is financially healthy and has no problem in meeting its short term obligations.
CJMB has a Current ratio of 2.59. This is amongst the best in the industry. CJMB outperforms 95.45% of its industry peers.
CJMB has a Quick Ratio of 2.47. This indicates that CJMB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.47, CJMB belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.47
CJMB Yearly Current Assets VS Current LiabilitesCJMB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CJMB have decreased strongly by -205.15% in the last year.
CJMB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.29%.
EPS 1Y (TTM)-205.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-76.09%
Revenue 1Y (TTM)-50.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-19.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CJMB Yearly Revenue VS EstimatesCJMB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CJMB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJMB Price Earnings VS Forward Price EarningsCJMB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

63.64% of the companies in the same industry are more expensive than CJMB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 45.82
EV/EBITDA N/A
CJMB Per share dataCJMB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CJMB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALLAN JMB INC

NASDAQ:CJMB (5/30/2025, 8:00:00 PM)

After market: 5.1 0 (0%)

5.1

-0.3 (-5.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap22.64M
AnalystsN/A
Price TargetN/A
Short Float %2.3%
Short Ratio0.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.45
P/FCF 45.82
P/OCF 41.9
P/B 7.14
P/tB 7.14
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY2.18%
OCF(TTM)0.12
OCFY2.39%
SpS1.48
BVpS0.71
TBVpS0.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.13%
ROE -72.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.05%
FCFM 7.53%
ROA(3y)6.05%
ROA(5y)N/A
ROE(3y)-1.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 32.15%
Cap/Sales 0.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.47
Altman-Z 7.2
F-Score3
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)375.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-205.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-76.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-19.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-203.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-92.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.28%
OCF growth 3YN/A
OCF growth 5YN/A